These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29048741)

  • 21. Can We Use Urinary Cytokine/Chemokine Analysis in Discriminating Ulcer-Type Interstitial Cystitis/Bladder Pain Syndrome?
    Jiang YH; Jhang JF; Kuo HC
    Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated Urine Levels of Macrophage Migration Inhibitory Factor in Inflammatory Bladder Conditions: A Potential Biomarker for a Subgroup of Interstitial Cystitis/Bladder Pain Syndrome Patients.
    Vera PL; Preston DM; Moldwin RM; Erickson DR; Mowlazadeh B; Ma F; Kouzoukas DE; Meyer-Siegler KL; Fall M
    Urology; 2018 Jun; 116():55-62. PubMed ID: 29580781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multimodal Single-Cell Analyses Outline the Immune Microenvironment and Therapeutic Effectors of Interstitial Cystitis/Bladder Pain Syndrome.
    Su F; Zhang W; Meng L; Zhang W; Liu X; Liu X; Chen M; Zhang Y; Xiao F
    Adv Sci (Weinh); 2022 Jun; 9(18):e2106063. PubMed ID: 35470584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and Safety of Low-dose Oral Prednisolone for Patients with Refractory Hunner-type Interstitial Cystitis.
    Akiyama Y; Niimi A; Nomiya A; Taguchi S; Yamada Y; Sato Y; Yamada D; Maeda D; Ushiku T; Kume H; Homma Y
    Eur Urol Open Sci; 2023 Oct; 56():1-8. PubMed ID: 37822513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Phenotyping Does Not Differentiate Hunner Lesion Subtype of Interstitial Cystitis/Bladder Pain Syndrome: A Relook at the Role of Cystoscopy.
    Doiron RC; Tolls V; Irvine-Bird K; Kelly KL; Nickel JC
    J Urol; 2016 Oct; 196(4):1136-40. PubMed ID: 27117441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression analysis of urine sediment: evaluation for potential noninvasive markers of interstitial cystitis/bladder pain syndrome.
    Blalock EM; Korrect GS; Stromberg AJ; Erickson DR
    J Urol; 2012 Feb; 187(2):725-32. PubMed ID: 22177197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment.
    Liu HT; Tyagi P; Chancellor MB; Kuo HC
    BJU Int; 2009 Nov; 104(10):1476-81. PubMed ID: 19522864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of prostaglandin E2 and E-series prostaglandin receptor in patients with interstitial cystitis.
    Wada N; Ameda K; Furuno T; Okada H; Date I; Kakizaki H
    J Urol; 2015 Jun; 193(6):1987-93. PubMed ID: 25595860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased mRNA expression of genes involved in pronociceptive inflammatory reactions in bladder tissue of interstitial cystitis.
    Homma Y; Nomiya A; Tagaya M; Oyama T; Takagaki K; Nishimatsu H; Igawa Y
    J Urol; 2013 Nov; 190(5):1925-31. PubMed ID: 23727186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of Urinary Cytokine and Chemokine Levels for Identifying Bladder Conditions and Predicting Treatment Outcomes in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
    Yu WR; Jiang YH; Jhang JF; Kuo HC
    Biomedicines; 2022 May; 10(5):. PubMed ID: 35625885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hunner lesion versus non-Hunner lesion interstitial cystitis/bladder pain syndrome.
    Whitmore KE; Fall M; Sengiku A; Tomoe H; Logadottir Y; Kim YH
    Int J Urol; 2019 Jun; 26 Suppl 1():26-34. PubMed ID: 31144757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome and Its Impact on Therapeutic Outcome.
    Lin HY; Lu JH; Chuang SM; Chueh KS; Juan TJ; Liu YC; Juan YS
    Diagnostics (Basel); 2021 Dec; 12(1):. PubMed ID: 35054241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficiency of O'Leary-Sant symptom index and problem index in the diagnosis of interstitial cystitis].
    Xu L; Zhang P; Zhang N; Yang Y; Wu ZJ; Zhang CH; Zhang XD
    Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(42):3347-50. PubMed ID: 24418029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensory Hyperinnervation Distinguishes Bladder Pain Syndrome/Interstitial Cystitis from Overactive Bladder Syndrome.
    Regauer S; Gamper M; Fehr MK; Viereck V
    J Urol; 2017 Jan; 197(1):159-166. PubMed ID: 27378135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of Bladder Capacity Under Anesthesia Following Multiple Recurrences and Repeated Surgeries of Hunner Lesions in Patients With Interstitial Cystitis.
    Furuta A; Suzuki Y; Igarashi T; Kimura T; Egawa S; Yoshimura N
    Int Neurourol J; 2022 Mar; 26(1):45-51. PubMed ID: 35368185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uronate peaks and urinary hyaluronic acid levels correlate with interstitial cystitis severity.
    Lokeshwar VB; Selzer MG; Unwala DJ; Estrella V; Gomez MF; Golshani R; Kester RR; Klumpp DJ; Gousse AE
    J Urol; 2006 Sep; 176(3):1001-7. PubMed ID: 16890679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urine biomarkers in ESSIC type 2 interstitial cystitis/bladder pain syndrome and overactive bladder with developing a novel diagnostic algorithm.
    Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC
    Sci Rep; 2021 Jan; 11(1):914. PubMed ID: 33441752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics of self-reported nocturia in patients with interstitial cystitis, and effects of bladder hydrodistention (with fulguration of Hunner lesions) on nocturia.
    Otsuka A; Suzuki T; Aki R; Matsushita Y; Tamura K; Motoyama D; Ito T; Sugiyama T; Miyake H
    Low Urin Tract Symptoms; 2019 Apr; 11(2):O141-O146. PubMed ID: 30010251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary nerve growth factor could be a biomarker for interstitial cystitis/painful bladder syndrome: a meta-analysis.
    Qu HC; Zhang W; Yan S; Liu YL; Wang P
    PLoS One; 2014; 9(9):e106321. PubMed ID: 25181532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [EARLY EXPERIENCE OF INTRAVESICAL INSTILLATION OF DIMETHYL SULFOXIDE 50% SOLUTION FOR HUNNER TYPE INTERSTITIAL CYSTITIS IN A CLINIC].
    Nanri M; Matsuo M
    Nihon Hinyokika Gakkai Zasshi; 2022; 113(4):122-127. PubMed ID: 37866931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.